EBV BZLF1 169-181 Peptide (HLA-B*18:01) - EECDSELEIKRY

The EBV BZLF1 169-181 peptide (EECDSELEIKRY) is a defined HLA-B*18:01-restricted epitope derived from the Epstein-Barr Virus immediate-early protein BZLF1 (Zta). It is commonly used for the stimulation and analysis of EBV-specific CD8+ T cells, supporting precise immune monitoring in virology and cancer research.

As a well-characterized MHC class I epitope, EBV BZLF-1 169-181 is particularly relevant for studying lytic EBV responses. The sequence EECDSELEIKRY enables targeted investigation of antigen-specific cytotoxic T lymphocyte (CTL) activity, T cell activation, and cytokine production in human samples.

The Epstein-Barr Virus (EBV) BZLF1 Trans-activator protein Peptide is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The BZLF1 Trans-activator protein Peptide, H-EECDSELEIKRY-OH (Uniprot: P03206 aa: 169-181) from JPT is produced under strict quality control and quality management.

EBV BZLF1 169-181 Peptide (HLA-B*18:01) - EECDSELEIKRY - Specifications

• Peptide sequence: H-EECDSELEIKRY-OH
• Amount: 1 mg
• Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
• Delivery Format: Freeze-dried in plastic vial
• Application(s):
• Condition(s)/Topic(s):
• Standard Delivery Time: approx. 10 days

Visit our webpage for more information on Peptide Tools to Study EBV

Your Custom or Scrambled Antigen Peptide!

Do you need a scrambled version of this antigen peptide?
We can produce scrambled versions for all our antigen peptides and other peptide sequences. These scrambled peptide versions are cross-checked against the Uniprot database to ensure that the scrambled sequence does not correspond to any natural sequence. Have a look at Scrambled Antigen Peptides!

Are you interested in other antigen peptides?
Choose sequence, amount and purity. We will assist you along the way: Custom Peptide Synthesis

JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool and MHC Multimer for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.

Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!